Latest Breaking News On - Prnewswire skylinedx - Page 2 : comparemela.com

SkylineDx Presents Pioneering Data at ASH 2023: SKY92 Risk Stratification in Multiple Myeloma Patients

SkylineDx Presents Pioneering Data at ASH 2023: SKY92 Risk Stratification in Multiple Myeloma Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPrnewswire skylinedxNoa biranJvalini dwarkasingProfessor at hackensack meridian school of medicineAmerican society of hematologyAmerican societyAssociate professorHackensack meridian schoolObservational multiple myeloma impact studyChief scientific officerSan diego california

Multicenter US Study Reveals CP-GEP s Profound Impact on Stratifying Melanoma Patients for Long-Term Survival

Multicenter US Study Reveals CP-GEP s Profound Impact on Stratifying Melanoma Patients for Long-Term Survival
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesJvalini dwarkasingPrnewswire skylinedxSociety for melanoma research congressUofl health brown cancer centerUniversity of louisvilleStratifying melanoma patientsMelanoma research congressGene expression profileChief scientific officerSan diego california

Real World Prospective Study shows clinical implementation of Merlin Assay (CP-GEP) in melanoma care

/PRNewswire/ SkylineDx an innovative diagnostics company focused on research & development of molecular diagnostics for oncology and inflammatory diseases,.

San diegoUnited statesPrnewswire skylinedxJvalini dwarkasingLaboratory developed testFalcon rd programMerlin study initiativeGene expression profileMelanoma eligibleSentinel lymph node biopsyMulticenter prospective dutch studyMerlin assaySan diego california

SkylineDx: Real World Prospective Study shows clinical implementation of Merlin Assay (CP-GEP) in melanoma care

SkylineDx: Real World Prospective Study shows clinical implementation of Merlin Assay (CP-GEP) in melanoma care
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan diegoPrnewswire skylinedxJvalini dwarkasingMerlin study initiativeLaboratory developed testFalcon rd programGene expression profileMelanoma eligibleSentinel lymph node biopsyMulticenter prospective dutch studyMerlin assaySan diego california

OPTIMUM trial demonstrates value of SKY92 in detecting high-risk myeloma and improving patient outcome

/PRNewswire/ SkylineDx, an innovative diagnostics company focused on research & development of molecular diagnostics for oncology and inflammatory diseases,.

United statesUnited kingdomSan diegoMartinf kaiserMartinf kaiserdefiningJvalini dwarkasingPrnewswire skylinedxInstitute of cancer researchInternational myeloma societyAnnual meetingClinical oncologyUnited kingdom myelomaConsultant hematologistCancer researchRoyal marsden hospital suttonChief scientific officer